advanced search

Welcome: Guest

log in

European Vaccines Market

Publication Date September 2008
Publisher Frost & Sullivan
Product Type Report
Pages 78
ISBN Number not applicable
Product Code FRS00555
Buy this product or for assistance call +44 20 7060 7474

Summary

The European Vaccines market discusses and analyses the evolving market scenario. The research service provides revenue estimation and forecast based on the factors that are expected drive and restrain the market in the forecast period. Challenges faced by the industry are analysed and strategic recommendations are discussed based on the current and future trends in the European Market.

Content

  • 1 Executive Summary
    • Executive Summary of the European Vaccines Market
      • Summary
  • 2 Glossary
    • Glossary of Terms
      • Key Acronyms
  • 3 Research Methodology
    • Research Methodology for the European Vaccines Market
      • Research Methodology
  • 4 Industry Challenges
    • Challenges for the European Vaccines Market
      • Challenges
  • 5 European Vaccines Market Outlook
    • Introduction
      • Disease Description
      • Vaccines Description
    • Country Overview
      • France
      • Germany
      • Italy
      • Spain
      • The United Kingdom
  • 6 Market Engineering Research for European Vaccines Market
    • European Vaccines Market
      • Market Engineering Research for the European Vaccines Market
      • Market Engineering Measurements
      • Market Drivers
      • Market Restraints
      • Revenue Forecasts
  • 7 Competitor Analysis
    • Portfolio Analysis
      • Market Share Analysis
      • Competitor Analysis
  • 8 Strategic Recommendations
    • Strategic Recommendations
      • Strategic Recommendations for the European Vaccines Market
  • 9 List of Key Industry Participants
    • Key Industry Participants
      • Key Industry Participants in the European Vaccines Market
  • 10 Decision Support Databases
    • Decision Support Databases
      • Government Healthcare Expenditure
      • EPO Biotech Patents
      • Pharmaceutical R&D Expenditure
      • per cent Government Biotech R&D Investment
      • Venture Capital Investment in Biotech R&D
Delivery Details

PDF:Delivered by email within 12 to 24 hours of placing the order (Mon-Fri

Industry Events

2nd International Conference on Drug Discovery and Therapy

01 Feb 10 to 04 Feb 10
Dubai, United Arab Emirates
view summary >>

Orphan & Ultra Orphan Drugs

13 Jan 10 to 14 Jan 10
Brussels, Belgium
view summary >>